Summary
GlobalData's clinical trial report, “AIDS - Related Primary CNS Lymphoma Global Clinical Trials Review, H2, 2018" provides an overview of AIDS - Related Primary CNS Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on AIDS - Related Primary CNS Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
F. Hoffmann-La Roche Ltd
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Clinical Trials by G7 Countries: Proportion of AIDS - Related Primary CNS Lymphoma to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Prominent Drugs 23
Clinical Trial Profile Snapshots 24
Appendix 30
Abbreviations 30
Definitions 30
Research Methodology 31
Secondary Research 31
About GlobalData 31
Contact Us 32
Disclaimer 32
Source 32
List of Tables
AIDS - Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Region, 2018* 7
AIDS - Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
AIDS - Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
AIDS - Related Primary CNS Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11
AIDS - Related Primary CNS Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
AIDS - Related Primary CNS Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Proportion of AIDS - Related Primary CNS Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2018* 15
AIDS - Related Primary CNS Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
AIDS - Related Primary CNS Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
AIDS - Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2018* 18
AIDS - Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2018* 19
AIDS - Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2018* 20
AIDS - Related Primary CNS Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 21
AIDS - Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22
AIDS - Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 23
List of Figures
AIDS - Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
AIDS - Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
AIDS - Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
AIDS - Related Primary CNS Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
AIDS - Related Primary CNS Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Proportion of AIDS - Related Primary CNS Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2018* 14
AIDS - Related Primary CNS Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
AIDS - Related Primary CNS Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
AIDS - Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2018* 18
AIDS - Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2018* 19
AIDS - Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2018* 20
AIDS - Related Primary CNS Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 21
AIDS - Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22
AIDS - Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 23
GlobalData Methodology 31
